StockWatch
·

Fredun Pharmaceuticals Ltd Q3 FY26 Results

FREDUNQ3 FY26 Results
Filing
MetricValue ( Cr)vs Q2 FY26
Revenue159.9311.4%
Total Income160.9210.8%
Expenditure146.9210.8%
PBT14.0010.2%
Net Profit10.4811.1%
OPM15.84%1.48pp
NPM6.51%0.02pp
EPS19.532.3%
View full financials

Informational and educational content only. Not investment advice.